- Presentations
- 3
- Markets
- 1
Kaletra is a brand of Lopinavir and Ritonavir marketed by AbbVie, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lopinavir and Ritonavir
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 80 mg/20 mg per mL oral solution, 100 mg/25 mg tablet, 200 mg/50 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kaletra 80 mg/20 mg per mL oral solutionOral Cold chain | AbbVie | US FDA | Available on request |
| Kaletra 100 mg/25 mg tabletOral Cold chain | AbbVie | US FDA | Available on request |
| Kaletra 200 mg/50 mg tabletOral Cold chain | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Kaletra
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.